Interleukin-10 inhibits interleukin-2-induced tumor necrosis factor production but does not reduce toxicity in C3H/HeN mice

Journal of Leukocyte Biology

Volumn 60, Issue 1, 1996, Pages 51-57

  Lentsch, Alex B ^a,b   Edwards, Michael J ^a,b   Sims, David E ^c   Nakagawa, Koji ^a   Wellhausen, Samuel R ^a   Miller, Frederick N ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Alveolar macrophages; Interleukin 2 receptor; Pleural effusion

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; GOLGI COMPLEX; IMMUNOTHERAPY; INTERFERON PRODUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG TOXICITY; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; ROUGH ENDOPLASMIC RETICULUM;

EID: 0029936022     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.1.51     Document Type: Article

References (33)

1. Grimm, E.A., Owen-Schaub, L. (1991) The IL-2 mediated amplification of cellular cytotoxicity. J. Cell Biochem. 45, 335-339.
2. Siegel, J.P., Puri, R.K. (1991) Interleukin-2 toxicity. J. Clin. Oncol. 9, 694-704.
3. Weidmann, E., Bergmann, L., Stock, J. Kirsten, R., Mitrou, P.S. (1992) Rapid cytokine release in cancer patients treated with interleukin-2. J. Immunother. 12, 123-131.
4. Konrad, M.W., DeWitt, S.K., Bradley, E.C., Goodman, G., Groves, E.C., Hersh, E.M., Krigel, R.L. Rudolph, A. (1992) Interferon-γ induced by administration of recombinant interleukin-2 to patients with cancer: kinetics, dose dependence, and correlation with physiological and therapeutic response. J. Immunother. 12, 55-63.
5. Faggioni, R., Allavena, P., Cantoni, L., Carelli, M., Demitri, M.T., Delgado, R., Gatti, S., Gnocchi, P., Isetta, A.M., Paganin, C., Echtenacher, B., Albini, E., Ghezzi, P. (1994) Mechanisms of interleukin-2-induced hydrothoraxy in mice: protective effect of endotoxin tolerance and dexamethasone and possible role of reactive oxygen intermediates. J. Immunother. 15, 194-201.
6. Strieter, R.M., Remick, D.G., Lynch, J.P., Spengler, R.N., Kunkel, S.L. (1989) Interleukin-2-induced tumor necrosis factor-alpha (TNF-alpha) gene expression in human alveolar macrophages and blood monocytes. Am. Rev. Respir. Dis. 139, 335-342.
7. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C.G., de Vries, J.E. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
8. Bogdan, C., Vodovotz, Y., Nathan, C. (1991) Macrophage deactivation by interleukin 10. J. Exp. Med. 174, 1549-1555.
9. Cassatella, M.A., Meda, L., Bonora, S., Ceska, M., Constantin, G. (1993) Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178, 2207-2211.
10. Jenkins, J.K., Malyak, M., Arend, W.P. (1994) The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res. 13, 47-54.
11. Joyce, D.A., Gibbons, D.P., Green, P., Steer, J.H., Feldmann, M., Brennan, F.M. (1994) Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur. J. Immunol. 24, 2699-2705.
12. Howard, M., Muchamuel, T., Andrade, S., Menon, S. (1993) Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177, 1205-1208.
13. Gerard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., Velu, T. (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177, 547-550.
14. Chernoff, A.E., Granowitz, E.V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J.B., Kennedy, J.S., Rabson, A.R., Wolff, S.M., Dinarello, C.A. (1995) A randomized, controlled trial of IL-10 in humans: Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154, 5492-5499.
15. Cohen, S.B., Katsikis, P.D., Feldmann, M., Londei, M. (1994) IL-10 enhances expression of the IL-2 receptor α chain on T cells. Immunology 83, 329-332.
16. Fluckiger, A.C., Garrone, P., Durand, I., Galizzi, J.P., Banchereau, J. (1993) Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J. Exp. Med. 178, 1473-1481.
17. Waldmann, T.A. (1991) The interleukin-2 receptor. J. Biol. Chem. 266, 2681-2684.
18. Heaton, K.M., Ju, G., Grimm, E.A. (1993) Human interleukin 2 analogues that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogues in cancer immunotherapy. Cancer Res. 53, 2597-2602.
19. Heaton, K.M., Ju, G., Grimm, E.A. (1994) Induction of lymphokine-activated killing with reduced secretion of interleukin-1β, tumor necrosis factor-α, and interferon-γ by interleukin-2 analogs. Ann. Surg. Oncol. 1, 198-203.
20. Chen, W.F., Zlotnik, A. (1991) IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147, 528-534.
21. Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M., O'Garra, A. (1991) IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822.
22. Ogle, C.K., Wu, J.Z., Mao, X., Szczur, K., Alexander, J.W., Ogle, J.D. (1994) Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6. Inflammation 18, 511-523.
23. Bogdan, C., Paik, J., Vodovotz, Y., Nathan, C. (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267, 23301-23308.
24. Hancock, W.W., Muller, W.A., Cotran, R.S. (1987) Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines. J. Immunol. 138, 185-191.
25. Economou, J.S., Hoban, M., Lee, J.D., Essner, R., Swisher, S., McBride, W., Hoon, D. B., Morton, D.L. (1991) Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity. Cancer Immunol. Immunother. 34, 49-52.
26. Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S.C., Seehra, J., London, L., Perussia, B. (1984) Response of resting human peripheral blood natural killer cells to interleukin 2. J. Exp. Med. 160, 1147-1169.
27. Hsu, D.H., Moore, K.W., Spits, H. (1992) Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4, 563-569.
28. Fraker, D.L., Langstein, H. N., Norton, J.A. (1989) Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity. J. Exp. Med. 170, 1015-1020.
29. Edwards, M.J., Heniford, B.T., Klar, E.A., Doak, K.W., Miller, F.N. (1992) Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy. J. Clin. Invest. 90, 637-641.
30. Peace, D.J., Cheever, M.A. (1989) Toxicity and therapeutic efficacy of high-dose interleukin-2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia. J. Exp. Med. 169, 161-173.
31. Ettinghausen, S.E., Puri, R.K., Rosenberg, S.A. (1988) Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. J. Natl. Cancer Inst. 80, 177-188.
32. 1-positive lymphoid cells in mediating the toxic effects of recombinant IL-2 in mice. J. Immunol. 141, 189-200.
33. Puri, R.K., Rosenberg, S.A. (1989) Combined effects of interferon alpha and interleukin 2 on the induction of a vascular leak syndrome in mice. Cancer Immunol. Immunother. 28, 267-274.